BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25640492)

  • 1. Assessment of melanoma histotypes and associated patient related factors: basis for a predictive statistical model.
    Haenssle HA; Hoffmann S; Buhl T; Emmert S; Schön MP; Bertsch HP; Rosenberger A
    J Dtsch Dermatol Ges; 2015 Jan; 13(1):37-45. PubMed ID: 25640492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of malignant melanoma according to subtype.
    Lin MJ; Mar V; McLean C; Wolfe R; Kelly JW
    Australas J Dermatol; 2014 Feb; 55(1):35-42. PubMed ID: 24283461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological behaviour of cutaneous malignant melanomas.
    Søndergaard K
    Pathology; 1985 Apr; 17(2):255-7. PubMed ID: 4047727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma thickness: the role of patients' characteristics, risk indicators and patterns of diagnosis.
    Haenssle HA; Hoffmann S; Holzkamp R; Samhaber K; Lockmann A; Fliesser M; Emmert S; Schön MP; Rosenberger A; Buhl T
    J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):102-8. PubMed ID: 24646029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical aspects and pathology of melanoma].
    Panizzon RG; Guggisberg D
    Ther Umsch; 1999 Jun; 56(6):302-8. PubMed ID: 10420811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy).
    Naldi L; Altieri A; Imberti GL; Gallus S; Bosetti C; La Vecchia C;
    Cancer Causes Control; 2005 Oct; 16(8):893-9. PubMed ID: 16132799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on cutaneous melanoma in Turkey: evaluation of 19-year data in a single tertiary centre and review of the literature.
    Baykal C; Atci T; Polat Ekinci A; Buyukbabani N
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):236-240. PubMed ID: 27519285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological type and biological behavior of primary cutaneous malignant melanoma. 2. An analysis of 86 cases located on so-called acral regions as plantar, palmar, and sub-/parungual areas.
    Søndergaard K
    Virchows Arch A Pathol Anat Histopathol; 1983; 401(3):333-43. PubMed ID: 6415910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for lentigo maligna melanoma compared with superficial spreading melanoma: a case-control study in Australia.
    Kvaskoff M; Siskind V; Green AC
    Arch Dermatol; 2012 Feb; 148(2):164-70. PubMed ID: 22004881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential clinical significance of alpha(v)Beta(3) expression in primary lesions of acral lentiginous melanoma and of other melanoma histotypes.
    Kageshita T; Hamby CV; Hirai S; Kimura T; Ono T; Ferrone S
    Int J Cancer; 2000 Mar; 89(2):153-9. PubMed ID: 10754493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual variants of melanoma: fact or fiction?
    Sagebiel RW
    Semin Oncol; 1996 Dec; 23(6):703-8. PubMed ID: 8970590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and dermoscopic characteristics of melanomas on nonfacial chronically sun-damaged skin.
    Jaimes N; Marghoob AA; Rabinovitz H; Braun RP; Cameron A; Rosendahl C; Canning G; Keir J
    J Am Acad Dermatol; 2015 Jun; 72(6):1027-35. PubMed ID: 25824275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The primary cutaneous melanoma. Clinical aspects and histopathology, basis for prognosis].
    Michalik EE
    Fortschr Med; 1982 Jun; 100(22):1027-32. PubMed ID: 7106667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant melanoma of the head and neck in Scotland: an eight-year analysis of trends in prevalence, distribution and prognosis.
    Cox NH; Jones SK; MacKie RM
    Q J Med; 1987 Aug; 64(244):661-70. PubMed ID: 3444872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors.
    Haenssle HA; Korpas B; Hansen-Hagge C; Buhl T; Kaune KM; Johnsen S; Rosenberger A; Schön MP; Emmert S
    Arch Dermatol; 2010 Mar; 146(3):257-64. PubMed ID: 20231495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
    Hoersch B; Leiter U; Garbe C
    Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple primary (even in situ) melanomas in a patient pose significant risk to family members.
    Chen T; Hemminki K; Kharazmi E; Ji J; Sundquist K; Fallah M
    Eur J Cancer; 2014 Oct; 50(15):2659-67. PubMed ID: 25103454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada Melanoma Study.
    Elwood JM; Gallagher RP; Worth AJ; Wood WS; Pearson JC
    J Natl Cancer Inst; 1987 Jan; 78(1):37-44. PubMed ID: 3467128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular melanomas: analysis of the casistic and relationship with thick melanomas and diagnostic delay.
    Betti R; Martino P; Vergani R; Gualandri L; Crosti C
    J Dermatol; 2008 Oct; 35(10):643-50. PubMed ID: 19017043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thick melanoma: the problem continues.
    Tejera-Vaquerizo A; Mendiola-Fernández M; Fernández-Orland A; Herrera-Ceballos E
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):575-9. PubMed ID: 18081751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.